Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

MNOV

MEDICINOVA INC

Healthcare · Biotechnology

$2.10Sep 28, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

MEDICINOVA INC shows accelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +241% YoY in Q2 FY2026.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue +241% YoY in Q2 FY2026

Pipeline evidence · 22d ago

MNOV's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on MNOV.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full MNOV earnings analysis

Reported figures for MEDICINOVA INC — research only, not investment advice.

Revenue YoY
+240.6%

Latest Intelligence

Updated

What happened recently for MEDICINOVA INC (MNOV) — events, not interpretation.

Event
Reported Q2 2026 revenue +241% YoY.
Also
Last session September 28, 2026 at $2.1.
Source
Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

MEDICINOVA INC (MNOV)

Healthcare · Biotechnology

Investment Snapshot above is the primary AlphaOS analysis for MEDICINOVA INC — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Industry:
Biotechnology
Market cap:
$103.36M
Revenue:
$186,980

MNOV earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow MEDICINOVA INC through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.